MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

CoLucid Pharmaceuticals Company Profile (NASDAQ:CLCD)

Consensus Ratings for CoLucid Pharmaceuticals (NASDAQ:CLCD) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $19.50 (224.46% upside)

Analysts' Ratings History for CoLucid Pharmaceuticals (NASDAQ:CLCD)
Show:
DateFirmActionRatingPrice TargetActions
11/10/2015William BlairInitiated CoverageBuy$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015Ladenburg ThalmannInitiated CoverageBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015Stifel NicolausInitiated CoverageBuy$15.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015Piper JaffrayInitiated CoverageOverweight$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/25/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha